CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
XXII
22nd Century Group, Inc.
There isn't enough reported data to score XXII yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
XXII Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Under pressure | |
| Unavailable |
XXII's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
XXII PE Valuation
XXII has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
XXII Forward outlook
There aren't enough analyst estimates for XXII to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the stronger earnings trend. Trailing diluted EPS is up 718% for CELH versus XXII down 321%.
XXII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2023 | -$6,293,082,986.17 | -$3,440,457,386.17 |
| Q3 2023 | -$5,904,070,560.00 | -$2,532,785,760.00 |
| Q2 2023 | -$3,673,836,000.00 | -$302,551,200.00 |
| Q1 2023 | -$3,241,620,000.00 | -$259,329,600.00 |
| Q4 2022 | -$2,852,625,600.00 | -$129,664,800.00 |
| Q3 2022 | -$3,371,284,800.00 | -$1,296,648,000.00 |
| Q2 2022 | -$3,371,284,800.00 | -$1,685,642,400.00 |
| Q1 2022 | -$2,982,290,400.00 | -$1,166,983,200.00 |
XXII lost $6,293,082,986.17 per share over the past year, and its loss has widened in each of the last four quarters.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over XXII on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over XXII on profitability, with a higher operating margin.
XXII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.9M | -30% |
| Q1 2026 | $4.1M | -31% |
| Q4 2025 | $3.5M | -12% |
| Q3 2025 | $4M | -33% |
| Q2 2025 | $4.1M | -49% |
| Q1 2025 | $6M | -7.9% |
| Q4 2024 | $4M | -45% |
| Q3 2024 | $5.9M | -67% |
XXII's revenue has slid since its 2023 peak: $3M last quarter, down 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -115% | -42 points |
| Q1 2026 | -74% | -31 points |
| Q4 2025 | -79% | +23 points |
| Q3 2025 | -80% | -23 points |
| Q2 2025 | -73% | -47 points |
| Q1 2025 | -43% | +25 points |
| Q4 2024 | -102% | -968 points |
| Q3 2024 | -57% | +345 points |
XXII's operating margin was −115% last quarter, down 42 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over XXII on cash generation, producing positive trailing cash flow while its opponent burns cash.
XXII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.3M | -$813K |
| Q1 2026 | -$3.1M | -$157K |
| Q4 2025 | $2.7M | +$7.1M |
| Q3 2025 | -$4M | -$977K |
| Q2 2025 | -$3.5M | +$1.3M |
| Q1 2025 | -$3M | -$724K |
| Q4 2024 | -$4.4M | +$1.1M |
| Q3 2024 | -$3M | +$11M |
XXII has burned cash in almost every quarter: −$9M over the past year, against −$14M the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
XXII Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +250% | +10 shares |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
XXII Net Leverage
XXII's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
XXII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.5 | Oversold |
| Stochastic | 0.0 | Oversold |
XXII's weekly RSI is 24 (oversold) and its Stochastic is 0 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
XXII PE vs Consumer Defensive Sector
XXII has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over XXII on trend strength, trading above more of its moving averages.
XXII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.9 | 95% below |
| 20 week MA | $134.2 | 99% below |
| 50 week MA | $3,909.0 | 100% below |
| 100 week MA | $265,401.1 | 100% below |
| 200 week MA | $1,346,419,789.7 | 100% below |
XXII is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over XXII on returns for 2026, with the stronger performance.
XXII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14,781,787,200.0 | $29,693,239,200.0 | +101% |
| 2021 | $29,693,239,200.0 | $39,547,764,000.0 | +33% |
| 2022 | $39,547,764,000.0 | $11,464,961,616.0 | -71% |
| 2023 | $11,464,961,616.0 | $160,957,238.4 | -99% |
| 2024 | $160,957,238.4 | $1,996,998.0 | -99% |
| 2025 | $1,996,998.0 | $15,221.5 | -99% |
| 2026 YTD | $15,221.5 | $1.30 | -100% |
XXII has finished four years in a row lower, and it's down 100% so far in 2026.